Features of the modern course of granulomatosis with polyangiitis (Wegener's granulomatosis) in children on the example of a clinical case in a teenage patient
DOI:
https://doi.org/10.15574/SP.2023.134.149Keywords:
Wegener’s granulomatosis, adolescent, systemic vasculitis, diagnosis, treatment, complicationsAbstract
The article introduces readers to a rare disease from the group of systemic vasculitis - Wegener’s granulomatosis. The prevalence of this disease in European countries ranges from 4.9 to 10.5 cases per 1 million adult population. A feature of the disease is the pathology of the upper respiratory tract at the beginning of the inflammatory process, which leads to long and difficult treatment of patients by otolaryngologists, as a result of which the correct diagnosis is delayed and the prognosis of the disease worsens. The disease is especially rare among children.
Purpose - to share the experience of diagnosis and treatment of a teenager with this extremely rare pathology. Complications of drug therapy and ways to solve them are considered in detail.
The conclusion of this experience is an understanding of the severity of the course of the disease and the need to use aggressive therapy already in its early stages in order to save the patient’s life.
The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent of the parents and the child was obtained for the study.
No conflict of interests was declared by the authors.
References
Beketova TV. (2012). Hranulematoz z polianhiitom, patohenetychno pov'iazanyi z ANTsA: osoblyvosti klinichnykh proiaviv. Nauchno-praktycheskaia revmatolohyia. 50 (6): 19-28.
Cottin V, Cordier J-F, Richeldi L. (2015). Orphan lung diseases (the clinical guide to rare lung disease). Springer: 611. https://doi.org/10.1007/978-1-4471-2401-6
Duzhyi I.D, Byzov VV. (2003). Trudnoshchi diahnostyky y uskladnennia pry hranulematozi Vehenera. Lik. Sprava. 7: 94-97.
Jennette JC, Falk RJ, Bacon PA et al. (2013). Revised international Chapel Hill consensus conference nomenclature of vasculitis. Arthritis Rheum. 65: 1-11.
Kovalenko VM, Shuba NM. (2013). Natsionalnyi pidruchnyk z revmatolohii. Za redaktsiieiu V.M. Kovalenka, N.M. Shuby. Kyiv: 320-328.
Lane S.E. (2005). Epidemiology of systemic vasculitis. Curr. Rheumatol. Rep. 7: 270-275. https://doi.org/10.1007/s11926-005-0036-5; PMid:16045829
Markov HY. (2010). Dyahnostyka y lechenye hranulematoza Vehenera. Vestnyk otorynolarynholohyy. 1: 19-20.
Ministerstvo zdravoohraneniya Rossii. (2017). Federalniye klynycheskye rekomendatsyy; Hranulematoz Vehenera (vozrastnaia hruppa - dety): 65.
Nasonov L. (2010). Klynycheskye rekomendatsyy. Moskva: HEOTAR-Medya: 752.
Sterlynh DzhV. (2001). Sekreti revmatolohyy. Per. s anhl. pod obshchei red. d-ra med. nauk, prof. V.N. Khyrmanova. Moskva: BYNOM, Sankt-Peterburh, Nevskyi Dyalekt: 750.
Watts R.A et al. (2001). Epidemiology of vasculitis in Europe. Ann. Rheum. Dis. 60 (12): 1156-1157. https://doi.org/10.1136/ard.60.12.1156a; PMid:11760724 PMCid:PMC1753455
Zerbino DD, Zemba OO. (2013). Hranulematoz Vehenera: uskladnennia ta prychyny smerti. Ukrainskyi medychnyi chasopys. 5 (97); IX/X.
Zerbyno DD, Chopiak VV. (2009). Klassyfykatsyy vaskulytov y krytycheskaia otsenka problemi. Sertse i sudyny. 4 (28): 93-100.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.